Critics often claim that GLP-1 agonists (like semaglutide and tirzepatide) only provide temporary weight loss, arguing that patients regain weight after stopping the medication.

Aspirin (acetylsalicylic acid) is one of the most widely studied drugs in history, primarily for its anti-inflammatory, pain-relieving, and cardiovascular benefits.